Arrowhead Pharmaceuticals Corp Stock Current Valuation
| 0HI3 Stock | 18.58 0.05 0.27% |
Valuation analysis of Arrowhead Pharmaceuticals helps investors to measure Arrowhead Pharmaceuticals' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Arrowhead Pharmaceuticals' Cash is comparatively stable compared to the past year. Cash And Short Term Investments is likely to gain to about 487.4 M in 2024, despite the fact that Total Cash From Operating Activities is likely to grow to (131.6 M). Fundamental drivers impacting Arrowhead Pharmaceuticals' valuation include:
Enterprise Value 2.3 B | Price Sales 91.9702 |
Overvalued
Today
Please note that Arrowhead Pharmaceuticals' price fluctuation is not too volatile at this time. Calculation of the real value of Arrowhead Pharmaceuticals is based on 3 months time horizon. Increasing Arrowhead Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Arrowhead stock is determined by what a typical buyer is willing to pay for full or partial control of Arrowhead Pharmaceuticals Corp. Since Arrowhead Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Arrowhead Stock. However, Arrowhead Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 18.58 | Real 15.61 | Hype 18.57 | Naive 17.21 |
The intrinsic value of Arrowhead Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Arrowhead Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Arrowhead Pharmaceuticals Corp helps investors to forecast how Arrowhead stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Arrowhead Pharmaceuticals more accurately as focusing exclusively on Arrowhead Pharmaceuticals' fundamentals will not take into account other important factors: Arrowhead Pharmaceuticals Corp Company Current Valuation Analysis
Arrowhead Pharmaceuticals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Arrowhead Pharmaceuticals Current Valuation | 2.32 B |
Most of Arrowhead Pharmaceuticals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arrowhead Pharmaceuticals Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Arrowhead Pharmaceuticals Corp has a Current Valuation of 2.32 B. This is 68.18% lower than that of the Commercial Services & Supplies sector and significantly higher than that of the Industrials industry. The current valuation for all United Kingdom stocks is 86.06% higher than that of the company.
Arrowhead Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Arrowhead Pharmaceuticals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Arrowhead Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Arrowhead Pharmaceuticals by comparing valuation metrics of similar companies.Arrowhead Pharmaceuticals is currently under evaluation in current valuation category among its peers.
Arrowhead Fundamentals
| Return On Equity | -1.52 | ||||
| Return On Asset | -0.41 | ||||
| Operating Margin | (27.85) % | ||||
| Current Valuation | 2.32 B | ||||
| Shares Outstanding | 88.02 M | ||||
| Shares Owned By Insiders | 4.46 % | ||||
| Shares Owned By Institutions | 79.70 % | ||||
| Price To Sales | 91.97 X | ||||
| Revenue | 240.74 M | ||||
| Gross Profit | 240.74 M | ||||
| EBITDA | (175.67 M) | ||||
| Net Income | (209.28 M) | ||||
| Total Debt | 115.17 M | ||||
| Book Value Per Share | 2.66 X | ||||
| Cash Flow From Operations | (153.89 M) | ||||
| Earnings Per Share | (1.07) X | ||||
| Number Of Employees | 525 | ||||
| Beta | 0.93 | ||||
| Market Capitalization | 180.7 B | ||||
| Total Asset | 765.55 M | ||||
| Retained Earnings | (1.03 B) | ||||
| Net Asset | 765.55 M |
About Arrowhead Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Arrowhead Pharmaceuticals Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arrowhead Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arrowhead Pharmaceuticals Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.